| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 636,385 | 642,954 | 650,073 | 658,106 | | Cost of Revenue | 234,631 | 235,792 | 242,243 | 239,626 | | | Gross Profit | 401,754 | 407,162 | 407,830 | 418,480 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 109,845 | 101,924 | 98,751 | 106,836 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 127,572 | 128,796 | 128,352 | 130,954 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 164,337 | 176,442 | 180,727 | 180,690 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,818) | 15,517 | 4,113 | 12,907 | | Earnings Before Interest And Taxes | 162,519 | 191,959 | 184,840 | 193,597 | | Interest Expense | 52,032 | 53,446 | 49,483 | 49,166 | | Income Before Tax | 110,487 | 138,513 | 135,357 | 144,431 | | Income Tax Expense | 43,107 | 38,441 | 50,624 | 52,264 | | Minority Interest | (226) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 67,154 | 100,072 | 84,733 | 92,167 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 67,154 | 100,072 | 84,733 | 92,167 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $67,154 | $100,072 | $84,733 | $92,167 |
|
0.45% Nasdaq 
0.20%
Income Statement
